MA20316A1 - Compose antibiotique,procede pour le preparer et compositions les contenant - Google Patents

Compose antibiotique,procede pour le preparer et compositions les contenant

Info

Publication number
MA20316A1
MA20316A1 MA20540A MA20540A MA20316A1 MA 20316 A1 MA20316 A1 MA 20316A1 MA 20540 A MA20540 A MA 20540A MA 20540 A MA20540 A MA 20540A MA 20316 A1 MA20316 A1 MA 20316A1
Authority
MA
Morocco
Prior art keywords
same
preparing
compositions containing
antibiotic compound
antibiotic
Prior art date
Application number
MA20540A
Other languages
English (en)
French (fr)
Inventor
Veikko Marttila Esko
Antero Uotila Jakko
Lauri Antero Marvola Marti
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of MA20316A1 publication Critical patent/MA20316A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
MA20540A 1984-01-06 1985-01-02 Compose antibiotique,procede pour le preparer et compositions les contenant MA20316A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (1)

Publication Number Publication Date
MA20316A1 true MA20316A1 (fr) 1985-10-01

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
MA20540A MA20316A1 (fr) 1984-01-06 1985-01-02 Compose antibiotique,procede pour le preparer et compositions les contenant

Country Status (38)

Country Link
US (1) US4599326A (OSRAM)
JP (1) JPS60158197A (OSRAM)
KR (1) KR900006237B1 (OSRAM)
AT (1) AT386414B (OSRAM)
AU (1) AU565688B2 (OSRAM)
BE (1) BE901411A (OSRAM)
BG (1) BG43189A3 (OSRAM)
CA (1) CA1224461A (OSRAM)
CH (1) CH666275A5 (OSRAM)
CS (1) CS247191B2 (OSRAM)
CY (1) CY1462A (OSRAM)
DE (1) DE3500179A1 (OSRAM)
DK (1) DK149776C (OSRAM)
ES (1) ES8605818A1 (OSRAM)
FI (1) FI77249C (OSRAM)
FR (1) FR2557878B1 (OSRAM)
GB (1) GB2152502B (OSRAM)
HK (1) HK11590A (OSRAM)
HU (1) HU196221B (OSRAM)
IE (1) IE57967B1 (OSRAM)
IL (1) IL73885A (OSRAM)
IS (1) IS2968A7 (OSRAM)
IT (1) IT1184304B (OSRAM)
KE (1) KE3841A (OSRAM)
LU (1) LU85721A1 (OSRAM)
MA (1) MA20316A1 (OSRAM)
MX (1) MX156277A (OSRAM)
NL (1) NL8403979A (OSRAM)
NO (1) NO160263C (OSRAM)
NZ (1) NZ210606A (OSRAM)
PH (1) PH22471A (OSRAM)
PL (1) PL144349B1 (OSRAM)
PT (1) PT79777B (OSRAM)
RO (1) RO91262B (OSRAM)
SE (1) SE461854B (OSRAM)
SU (1) SU1410866A3 (OSRAM)
YU (1) YU44485B (OSRAM)
ZA (1) ZA8410143B (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
CA2491572C (en) * 2002-07-05 2010-03-23 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opiods and other drugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
CA2543181A1 (en) * 2003-10-31 2005-05-12 Alza Corporation Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin
SI1765292T1 (en) 2004-06-12 2018-04-30 Collegium Pharmaceutical, Inc. Formulations of medicines to discourage abuse
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
WO2006025882A2 (en) 2004-08-25 2006-03-09 The Uab Research Foundation Absorption enhancers for drug administration
EP2505189B1 (en) 2006-06-23 2018-08-08 Aegis Therapeutics, LLC Stabilizing alkylglycoside compositions and method thereof
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2012158964A2 (en) 2011-05-18 2012-11-22 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals for osteoporosis
JP6525456B2 (ja) 2012-11-20 2019-06-05 メデリス ダイアビーティーズ，エルエルシー インスリン抵抗性のための改善されたペプチド製剤
EP4047023A1 (en) 2012-11-20 2022-08-24 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
NZ726623A (en) 2014-05-28 2020-02-28 Mederis Diabetes Llc Improved peptide pharmaceuticals for insulin resistance
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
JP6938682B2 (ja) 2017-05-19 2021-09-22 ルネラ・バイオテック・インコーポレーテッド アンチミトシン：癌幹細胞を根絶するためのミトコンドリア生合成の標的阻害薬
CA3083487A1 (en) 2017-12-01 2019-06-06 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
AU2019217643B2 (en) 2018-02-06 2021-10-28 ARS Pharmaceuticals Operations, Inc. Intranasal epinephrine formulations and methods for the treatment of disease
MX2021007347A (es) * 2018-12-17 2021-07-15 Lunella Biotech Inc Terapias de combinacion triple para anti-envejecimiento.
CN113573715A (zh) * 2018-12-17 2021-10-29 卢内拉生物技术有限公司 用于靶向线粒体和杀死癌症干细胞的三联疗法
EA202091615A1 (ru) 2018-12-21 2021-03-05 Аегис Терапьютикс, Ллс Интраназальные составы на основе эпинефрина и способы лечения заболевания

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
FR2557878B1 (fr) 1988-01-15
FR2557878A1 (fr) 1985-07-12
FI77249C (fi) 1989-02-10
IL73885A0 (en) 1985-03-31
SE461854B (sv) 1990-04-02
KR900006237B1 (ko) 1990-08-27
LU85721A1 (fr) 1985-07-24
AU565688B2 (en) 1987-09-24
IL73885A (en) 1988-10-31
FI850023L (fi) 1985-07-07
JPS60158197A (ja) 1985-08-19
BG43189A3 (en) 1988-04-15
DK149776B (da) 1986-09-29
US4599326A (en) 1986-07-08
GB2152502A (en) 1985-08-07
PT79777B (en) 1986-10-21
YU2085A (en) 1987-12-31
IE850022L (en) 1985-07-06
DE3500179C2 (OSRAM) 1989-08-24
PH22471A (en) 1988-09-12
RO91262A (ro) 1987-06-30
CA1224461A (en) 1987-07-21
PL144349B1 (en) 1988-05-31
FI77249B (fi) 1988-10-31
NO160263B (no) 1988-12-19
ES8605818A1 (es) 1986-04-01
DK149776C (da) 1987-04-21
AU3705984A (en) 1985-07-11
IT8519012A0 (it) 1985-01-04
DK5884A (da) 1985-07-07
FI850023A0 (fi) 1985-01-03
HK11590A (en) 1990-02-23
JPH029040B2 (OSRAM) 1990-02-28
SU1410866A3 (ru) 1988-07-15
PT79777A (en) 1985-01-01
IE57967B1 (en) 1993-06-02
AT386414B (de) 1988-08-25
NO160263C (no) 1989-03-29
KE3841A (en) 1989-04-07
IS2968A7 (is) 1985-04-03
CH666275A5 (de) 1988-07-15
ZA8410143B (en) 1985-08-28
ES539349A0 (es) 1986-04-01
PL251457A1 (en) 1985-11-05
DE3500179A1 (de) 1985-07-18
NZ210606A (en) 1987-08-31
CY1462A (en) 1989-07-21
BE901411A (fr) 1985-04-16
NO850007L (no) 1985-07-08
ATA985A (de) 1988-01-15
SE8406671D0 (sv) 1984-12-28
RO91262B (ro) 1987-07-01
YU44485B (en) 1990-08-31
HU196221B (en) 1988-10-28
IT1184304B (it) 1987-10-28
GB2152502B (en) 1987-10-07
HUT37628A (en) 1986-01-23
DK5884D0 (da) 1984-01-06
GB8432368D0 (en) 1985-02-06
KR850005452A (ko) 1985-08-26
NL8403979A (nl) 1985-08-01
MX156277A (es) 1988-08-04
SE8406671L (sv) 1985-07-07
CS247191B2 (en) 1986-12-18

Similar Documents

Publication Publication Date Title
MA20316A1 (fr) Compose antibiotique,procede pour le preparer et compositions les contenant
PH21995A (en) Antibiotic compounds, their composition and process for the preparation of said compound
GB2171695B (en) Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
AU585561B2 (en) New peptide-aldehydes, process for the preparation thereof and pharmaceutical compositions containing the same
BE890574A (fr) Derive d'aminoalcoyl-furanne, procede pour sa preparation et composition pharmaceutique le contenant
BE893010A (fr) Compose stable de sulfate de glucosamine, son procede de preparation et compositions pharmaceutiques les contenant
FI851269A0 (fi) Anlaeggning foer kontinuerlig pressning av en pressgodsmatta i samband med framstaellningen av spaonplattor, fiberplattor och liknande.
IL64345A (en) Substituted phenoxypropanolamine derivatives,process for the production thereof and pharmaceutical compositions containing the same
DE3167997D1 (en) Tetrazole derivatives, process for the preparation thereof, and anti-ulcer composition containing the same
FR2565227B1 (fr) 1,24-dihydroxy-22-vitamines d3 et procede pour les preparer
FR2554444B1 (fr) 1,25-dihydroxyvitamines d2 et procedes pour les preparer
IL62960A0 (en) Imidazoazole compounds,their production and pharmaceutical compositions containing them
FR2521135B1 (fr) Composes polyanioniques, procede pour les preparer et compositions les contenant
EP0159708A3 (en) Chartreusin derivatives, salts thereof, antitumorous compositions containing the same, and processes for produing the same
FI823360A7 (fi) Uudet 3-fenyyli-1-indanamiinit ja menetelmä niiden valmistamiseksi ja niitä sisältävät koostumukset.
FR2552433B1 (fr) Nouveaux derives de 1,3,4-thiadiazole, procede pour leur preparation et leur utilisation comme agents anti-ulcere
DK206482A (da) Vaekstmediesammensaetning
FR2573762B1 (fr) Derives 4-hydroxyphenylthioalkyliques substitues, compositions les contenant et leur procede d'emploi
FR2590260B1 (fr) Nitro-anthracycline, aglycone correspondante, procedes pour les preparer, composition pharmaceutique correspondante
PT77428A (fr) Procede pour preparer de nouvelles amino-2-substitue-5-oxazoli-nes-2 et des compositions les contenant
DE3264578D1 (en) Thio-substituted-1,3,5-triazine-diamines and -triamines useful as prevulcanization inhibitors
DE3562370D1 (en) Amide compounds, process for preparing the same and pharmaceutical compositions containing the same
FR2549042B1 (fr) Procede pour la preparation de la 3,11-dimethyl-2-nonacosanone
PT72625B (en) Process for the preparation of 1-(3,5-diclorobenzoyl)-3-phenyl-pyrazolines having mildenicide effect
MA20115A1 (fr) (Delta3-thiadiazoline-1,2,3 ylidene-5)-urees, procede pour les preparer et produits regulateurs de croissance et defoliants contenant de telles urees.